Browse All Treatments

Showing 1856 records.


Page 48 of 186 1 46 47 48 49 50 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
47118.0 monthsHormone-refractory prostate cancer3Biologic therapyUniversity of Athens School of MedicineGreeceJan 2004
Treatment Details: Patients: This Phase II study involved 38 patients with hormone refractory prostate cancer. Patients were divided into two groups: Group 1 and Group 2. The average age of patient... read more
47218.0 monthsHormone refractory prostate cancer4ChemotherapyHospital Germans Trias i PujolSpainMar 2005
Treatment Details: Patients: This Phase II study enrolled 30 men with hormone refractory metastatic prostate cancer. The median age was 69. Metastatic sites included bone, lymph nodes, lung, and li... read more
47318.0 monthsPeritoneal carcinomatosis from colon adenocarcinoma4Chemotherapy, Biologic therapy, SurgeryUniversity of PadovaItalyJun 2003
Treatment Details: Patients: This Phase II study involved 46 patients treated for peritoneal carcinomatosis from colon adenocarcinoma. Treatment: Thirty-four patients were treated with complete c... read more
47418.0 monthsRecurrent epithelial ovarian cancer and fallopian tube or primary peritoneal cancer4ChemotherapyM.D. Anderson Cancer CenterUnited StatesJun 2014
Treatment Details: Patients: This phase 2 study involved previously treated, persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma patients who were divided into... read more
47518.0 monthsHepatocellular Carcinoma5ChemotherapyMie University School of MedicineJapanNov 2014
Treatment Details: Patients: This phase 2 study involved 35 hepatocellular carcinoma patients. The average patient age was 74 years and 69% were male. Treatment: Patients received chemotherapy ... read more
47618.0 monthsMetastatic breast cancer5Chemotherapy, Biologic therapyUniversity of PittsburghUnited StatesNov 2011
Treatment Details: Patients: This phase II study involved women with previously treated but recurrent or metastatic breast cancer who were divided into two separate treatment groups. Group A includ... read more
47718.0 monthsMetastatic colorectal cancer5Chemotherapy, Biologic therapyHospital La Paz/Autónoma University School of MedicineSpainApr 2010
Treatment Details: Patients: This study involved 59 metastatic colorectal cancer patients with a median age of 75 years, 58% of whom were male. Treatment: Patients were treated with the chemothe... read more
47818.0 monthsAdvanced urothelial cancer 4ChemotherapyAthens University Medical SchoolGreeceApr 2013
Treatment Details: Patients: This phase 3 study involved advanced urothelial cancer patients who were divided into two separate treatment groups. Group A consisted of 63 patients with a median age ... read more
47918.0 monthsMalignant pleural mesothelioma5RadiationMount Sinai Medical CenterUnited StatesJul 2012
Treatment Details: Patients: This study involved 36 malignant pleural mesothelioma patients. The median patient age was 67 years and 81% were male. Treatment: Patients were treated with intensi... read more
48018.0 monthsAdvanced cutaneous T-cell lymphoma5ChemotherapyMemorial Sloan-Kettering Cancer CenterUnited StatesNov 2013
Treatment Details: Patients: This phase 2 study involved 37 advanced cutaneous T-cell lymphoma patients. The median patient age was 56 years and 54% were male. Treatment: Patients were treated ... read more
Page 48 of 186 1 46 47 48 49 50 186